Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
30.3%
% of ARKG's 35 holdings also in GNOM
24.4%
% of GNOM's 41 holdings also in ARKG
Overlap by Weight
Sector Drift (ARKG minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ARKG |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
VERACYTE INC | 5.2% | 5.1% | 5.1% |
|
NATERA INC | 5.0% | 5.4% | 5.0% |
|
CRISPR THERAPEUTICS AG | 6.9% | 3.6% | 3.6% |
|
BEAM THERAPEUTICS, INC. | 4.3% | 3.6% | 3.6% |
|
10X GENOMICS INC CLASS A | 3.4% | 2.6% | 2.6% |
Position Highlights (Non-Overlapping Exposures)
ARKG Overweight Relative to GNOM
|
TWIST BIOSCIENCE CORP. | 9.2% |
|
RECURSION PHARMACEUTICALS, INC CLASS | 7.2% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | 5.6% |
|
GUARDANT HEALTH, INC. | 4.5% |
|
SCHRODINGER, INC. | 4.1% |
|
IONIS PHARMACEUTICALS, INC. | 3.9% |
|
CRISPR THERAPEUTICS AG | 3.3% |
 |
ALCOBRA LTD | 3.0% |
|
CAREDX, INC. | 2.9% |
|
NURIX THERAPEUTICS, INC. | 2.8% |
ARKG Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.7% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -4.2% |
|
BIO-TECHNE CORPORATION | -4.2% |
|
QIAGEN NV | -4.2% |
 |
BIONTECH SE SPONSORED ADR | -4.1% |
|
AGILENT TECHNOLOGIES INC | -4.0% |
|
SAREPTA THERAPEUTICS INC | -3.6% |
|
BIOMARIN PHARMACEUTICAL INC | -3.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.2% |
|
ALNYLAM PHARMACEUTICALS INC | -3.2% |